Purpose: The prevalence of most minor cardiovascular manifestations in Marfan syndrome (MFS) is unknown. We assessed the prevalence of minor cardiovascular manifestations in MFS to evaluate their ...
Background Recurrent mitral regurgitation (MR) remains a major limitation of mitral valve (MV) repair in patients with ...
Therapeutics Market Size accelerated to USD 10.60 billion in 2024, up from USD 9.22 billion in 2023, and is now projected to expand aggressively to USD 35.09 billion by 2033, recording a CAGR of 14.2% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback